- Email: [email protected]
15
JO U R N A L OF GE RI A TR IC O N C OLOG Y 3 ( 20 1 2 ) S 1 – S9
in the Senior Adult Oncology Program at the Moffitt Cancer Center. She earned her medical diploma and her medical PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specializing in Oncology–Hematology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her research focuses on cancer in the elderly. Her main areas of investigation are comorbidity, comprehensive assessment, and prediction/prevention of treatment toxicity in older cancer patients. She served as Chair of the Eastern Cooperative Oncology Group's Subcommittee on Aging and is presently involved in the South West Oncology Group. She also is the Immediate Past President of the International Society of Geriatric Oncology (SIOG), of which she is also a founding board member. She served on the ASCO Education and Scientific Program Committees, and is an Editorial Board member of the Journal of Clinical Oncology. Dr. Extermann was presented at ASCO 2009 with the B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology. doi:10.1016/j.jgo.2012.09.117
Corinne Faivre-Finn Corinne Faivre-Finn MD PhD is an internationally recognised Consultant Clinical Oncologist and an Honorary Senior Lecturer in Manchester with an interest in lung cancer. Dr. Faivre-Finn trained in Paris until 1998 and took a consultant post in the UK, at the Christie Hospital in 2001. Her interests lie in the development of multimodality treatments for stage III non small-cell lung cancer and limited disease small-cell lung cancer. She is also interested in the development of stereotactic radiotherapy for early stage NSCLC and early phase trials combining thoracic radiotherapy and mechanism based therapies. She is an active member of the EORTC radiotherapy and lung groups and became the Radiotherapy Chair of the EORTC Lung Group in 2008. She is also the chair of the multimodality working group of the European Thoracic Oncology Platform (ETOP). She is involved with the trial management groups of several UK clinical trials in lung cancer and is the Chief Investigator of several trials including the international CONVERT study looking at the optimisation of concurrent chemo-radiation in limited disease smallcell lung cancer.
S3
Fallowfield lives in Brighton and has 2 adult children one a consultant hepatologist and the other a paediatric community nurse. doi:10.1016/j.jgo.2012.09.119
Giovanni Gambassi Dipartimento di Scienze Gerontologiche e Geriatriche, Università Cattolica del Sacro Cuore, Rome, Italy Dr. Gambassi is a Professor of internal medicine — geriatrics at the Università Cattolica del Sacro Cuore in Rome, Italy where he is affiliated with the Dipartimento di Scienze Gerontologiche e Geriatriche, and serves as the chief of the Geriatric Division. He spent five years (1988– 1994) at the National Institutes of Health and Johns Hopkins University contributing seminal work on the molecular regulation of myocardial contractility. While appointed as Visiting Professor at Brown University in Providence (1996–1999), Dr. Gambassi established the Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. This group has collected an administrative database established as result of the mandatory application of the RAI-MDS in all the Medicare/ Medicaid nursing homes in the United States. Dr. Gambassi has been the SAGE scientific co-director ever since and contributed several important studies, in addition to securing a substantial amount of grant funding. Since 1998 he has been named Adjunct Professor at Brown University and Visiting Professor at the Division of Aging at Harvard Medical school in Boston. Dr. Gambassi is an author of over 150 original publications and numerous review articles, book chapters; he has been an invited speaker in over 200 occasions. doi:10.1016/j.jgo.2012.09.120
Jim George Dr. Jim George qualified at the University of Liverpool in 1977. He completed his general medical and specialist training in Liverpool, Aberdeen and Leeds. He was appointed a Consultant in General Medicine and Geriatrics in 1986 in Carlisle. He has a specialist interest in Dementia and Delirium and was a member of the NICE guideline development group for the Delirium Guidelines. He has published extensively on various aspects of Delirium and has also won the National BUPA Elderly Care Award for his work on Delirium.
doi:10.1016/j.jgo.2012.09.118 doi:10.1016/j.jgo.2012.09.121 Lesley Fallowfield Psycho-oncology, Brighton & Sussex Medical School, University of Sussex, UK Lesley Fallowfield is Professor of Psycho-oncology at Brighton & Sussex Medical School, University of Sussex where she is Director of the Sussex Health Outcomes Research & Education in Cancer (SHORE-C) group. Professor Fallowfield originally trained as a nurse at Guy's Hospital London but then did a BSc in Experimental Psychology at Sussex. She was a senior lecturer in health psychology at the Royal London Medical College where she gained a career development fellowship and a major programme grant from the Cancer Research Campaign. In 1991 she became full-time Director of the Psychosocial Oncology Group. Professor Fallowfield was awarded the first European chair in Psychooncology from University College London in 1997. Her research interests are wide and include the measurement of quality of life in clinical trials of cancer therapy and the training of communication skills for health care professionals in cancer. She has published over 300 papers, many book chapters and 3 text books. She lectures and runs training workshops throughout the world in psychosocial oncology, quality of life assessment and communication skills. Professor
Ioannis Gioulbasanis Medical Oncologist, University Hospital of Larisa, Greece Ioannis Gioulbasanis, MD, PhD has graduated from the Medical School of Aristotle's University of Thessaloniki in 1998 and received a Diploma of Medical Oncology from the University Hospital of Heraklion-Crete, in 2009. Since then, I work as a Medical Oncology Specialist for the Department of Medical Oncology, University Hospital of Larissa in which I have organized the multidisciplinary supportive care team. His field of expertise is the nutritional assessment of cancer patients. In 2011, he presented his Ph.D Thesis titled: “Assessment of nutritional status in metastatic lung cancer patients based on the Mini Nutritional Assessment (MNA) protocol: relations with laboratory parameters indicative of malnutrition — cachexia and with clinical outcomes”1. This particular research documented that MNA outperformed weight loss history as a nutritional screening method and could further refine prognostication2. Our center is participating in the Canadian International network on Cancer-Associated Cachexia. The major investigational project is the
in the Senior Adult Oncology Program at the Moffitt Cancer Center. She earned her medical diploma and her medical PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specializing in Oncology–Hematology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her research focuses on cancer in the elderly. Her main areas of investigation are comorbidity, comprehensive assessment, and prediction/prevention of treatment toxicity in older cancer patients. She served as Chair of the Eastern Cooperative Oncology Group's Subcommittee on Aging and is presently involved in the South West Oncology Group. She also is the Immediate Past President of the International Society of Geriatric Oncology (SIOG), of which she is also a founding board member. She served on the ASCO Education and Scientific Program Committees, and is an Editorial Board member of the Journal of Clinical Oncology. Dr. Extermann was presented at ASCO 2009 with the B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology. doi:10.1016/j.jgo.2012.09.117
Corinne Faivre-Finn Corinne Faivre-Finn MD PhD is an internationally recognised Consultant Clinical Oncologist and an Honorary Senior Lecturer in Manchester with an interest in lung cancer. Dr. Faivre-Finn trained in Paris until 1998 and took a consultant post in the UK, at the Christie Hospital in 2001. Her interests lie in the development of multimodality treatments for stage III non small-cell lung cancer and limited disease small-cell lung cancer. She is also interested in the development of stereotactic radiotherapy for early stage NSCLC and early phase trials combining thoracic radiotherapy and mechanism based therapies. She is an active member of the EORTC radiotherapy and lung groups and became the Radiotherapy Chair of the EORTC Lung Group in 2008. She is also the chair of the multimodality working group of the European Thoracic Oncology Platform (ETOP). She is involved with the trial management groups of several UK clinical trials in lung cancer and is the Chief Investigator of several trials including the international CONVERT study looking at the optimisation of concurrent chemo-radiation in limited disease smallcell lung cancer.
S3
Fallowfield lives in Brighton and has 2 adult children one a consultant hepatologist and the other a paediatric community nurse. doi:10.1016/j.jgo.2012.09.119
Giovanni Gambassi Dipartimento di Scienze Gerontologiche e Geriatriche, Università Cattolica del Sacro Cuore, Rome, Italy Dr. Gambassi is a Professor of internal medicine — geriatrics at the Università Cattolica del Sacro Cuore in Rome, Italy where he is affiliated with the Dipartimento di Scienze Gerontologiche e Geriatriche, and serves as the chief of the Geriatric Division. He spent five years (1988– 1994) at the National Institutes of Health and Johns Hopkins University contributing seminal work on the molecular regulation of myocardial contractility. While appointed as Visiting Professor at Brown University in Providence (1996–1999), Dr. Gambassi established the Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. This group has collected an administrative database established as result of the mandatory application of the RAI-MDS in all the Medicare/ Medicaid nursing homes in the United States. Dr. Gambassi has been the SAGE scientific co-director ever since and contributed several important studies, in addition to securing a substantial amount of grant funding. Since 1998 he has been named Adjunct Professor at Brown University and Visiting Professor at the Division of Aging at Harvard Medical school in Boston. Dr. Gambassi is an author of over 150 original publications and numerous review articles, book chapters; he has been an invited speaker in over 200 occasions. doi:10.1016/j.jgo.2012.09.120
Jim George Dr. Jim George qualified at the University of Liverpool in 1977. He completed his general medical and specialist training in Liverpool, Aberdeen and Leeds. He was appointed a Consultant in General Medicine and Geriatrics in 1986 in Carlisle. He has a specialist interest in Dementia and Delirium and was a member of the NICE guideline development group for the Delirium Guidelines. He has published extensively on various aspects of Delirium and has also won the National BUPA Elderly Care Award for his work on Delirium.
doi:10.1016/j.jgo.2012.09.118 doi:10.1016/j.jgo.2012.09.121 Lesley Fallowfield Psycho-oncology, Brighton & Sussex Medical School, University of Sussex, UK Lesley Fallowfield is Professor of Psycho-oncology at Brighton & Sussex Medical School, University of Sussex where she is Director of the Sussex Health Outcomes Research & Education in Cancer (SHORE-C) group. Professor Fallowfield originally trained as a nurse at Guy's Hospital London but then did a BSc in Experimental Psychology at Sussex. She was a senior lecturer in health psychology at the Royal London Medical College where she gained a career development fellowship and a major programme grant from the Cancer Research Campaign. In 1991 she became full-time Director of the Psychosocial Oncology Group. Professor Fallowfield was awarded the first European chair in Psychooncology from University College London in 1997. Her research interests are wide and include the measurement of quality of life in clinical trials of cancer therapy and the training of communication skills for health care professionals in cancer. She has published over 300 papers, many book chapters and 3 text books. She lectures and runs training workshops throughout the world in psychosocial oncology, quality of life assessment and communication skills. Professor
Ioannis Gioulbasanis Medical Oncologist, University Hospital of Larisa, Greece Ioannis Gioulbasanis, MD, PhD has graduated from the Medical School of Aristotle's University of Thessaloniki in 1998 and received a Diploma of Medical Oncology from the University Hospital of Heraklion-Crete, in 2009. Since then, I work as a Medical Oncology Specialist for the Department of Medical Oncology, University Hospital of Larissa in which I have organized the multidisciplinary supportive care team. His field of expertise is the nutritional assessment of cancer patients. In 2011, he presented his Ph.D Thesis titled: “Assessment of nutritional status in metastatic lung cancer patients based on the Mini Nutritional Assessment (MNA) protocol: relations with laboratory parameters indicative of malnutrition — cachexia and with clinical outcomes”1. This particular research documented that MNA outperformed weight loss history as a nutritional screening method and could further refine prognostication2. Our center is participating in the Canadian International network on Cancer-Associated Cachexia. The major investigational project is the